Mifepristone Induction for Fetal Demise (MIFD)
Mifepristone Induction for Fetal Demise, a Randomized Control Trial
Sponsor: Montefiore Medical Center
Terminated
unable to recruit. Projected completion was 2018 however, enrollment and recruitment were difficult. The study was terminated due to inability to enroll.
Other terminated trials from Montefiore Medical Center
Listed as NCT02620904, this PHASE4 trial focuses on Fetal Death and Intrauterine Fetal Demise and remains terminated or withdrawn. Sponsored by Montefiore Medical Center, it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
▶ Show 7 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
-
Mar 2021 — Dec 2021 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE4
-
Sep 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Feb 2019 — Sep 2019 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Montefiore Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .